Red flags, when to seek clinical care first

Red flags (alarm features) are gut symptoms or findings that shift the clinical question from “which diet or supplement might help?” to “is there a condition that needs diagnosis and treatment first?” Consumer microbiome reports do not detect most of these scenarios. When they are present, a stool sequencing panel is usually secondary, not a substitute for history, examination, and targeted labs or imaging.

This page lists common alarm features used in IBS and functional gut guidelines. It is not a complete emergency guide, severe pain, high fever, or collapse need urgent care regardless of gut history.


Alarm symptoms, seek medical assessment promptly

The table below combines features emphasised in Rome IV functional bowel criteria and ACG IBS guidance when organic disease must be considered before labelling symptoms as functional.

FeatureWhy it mattersDo not rely on a microbiome test to
Unintentional weight lossMalabsorption, IBD, cancer, hyperthyroidism, eating disorders (also clinical)“Explain” weight change via taxa lists
Rectal bleeding or black/tarry stoolsColorectal lesions, IBD, haemorrhoids (benign but need confirmation)Distinguish source or severity
Iron-deficiency anaemia (or known low haemoglobin)Occult GI blood loss, coeliac disease, IBDReplace blood work
Nocturnal diarrhoea (waking to pass stool)More common in organic inflammation than typical IBSRule out IBD
Persistent or worsening pain with feverInfection, IBD flare, surgical abdomenDiagnose infection
New symptoms after age 50 without prior workupHigher pre-test probability of structural diseaseScreen for cancer
Family history of colorectal cancer, IBD, or coeliac disease with compatible symptomsRaises referral thresholdReplace family-history risk assessment
Progressive dysphagia or persistent vomitingObstruction, motility disorder, malignancyAssess upper GI tract

Age and duration context: long-standing symptoms since young adulthood, with stable pattern and no alarms, more often fit functional disorders, but one normal microbiome sample does not prove that history.


When microbiome testing is secondary or misleading

SituationWhy the panel is a poor first step
Alarm features presentSequencing does not stage IBD, locate bleeding, or detect coeliac autoimmunity
Acute severe illnessInfection, dehydration, surgical abdomen need urgent clinical care
Unexplained iron deficiencyRequires endoscopy/serology pathways, not dysbiosis scores
Report says “normal” or “balanced”Asymptomatic and symptomatic people overlap widely in composition (healthy microbiome review)
Vendor “inflammation score” elevated but calprotectin not measuredAlgorithm output is not interchangeable with fecal calprotectin, see Gut inflammation markers

Stool microbiome testing can still play a later role for hypothesis generation (e.g. post-antibiotic ecology, research interest) after alarms are addressed, see Reading your microbiome report.


IBS diagnosis vs exclusion workup

Irritable bowel syndrome (IBS) in research and clinic is often defined by Rome IV symptom criteria: recurrent abdominal pain related to defecation, with associated stool frequency or form changes, in the absence of alarms that mandate other investigation (Sperber et al., 2017).

In practice, “IBS” is not always a single visit label:

PathwayWhat happens
Young patient, typical IBS pattern, no alarmsMany clinicians treat empirically (diet, fibre, stress) with selective testing
Alarms, anaemia, or strong IBD suspicionCalprotectin, coeliac serology, colonoscopy, or other workup before long-term functional framing
Mixed pictureSymptoms may overlap (IBS + coeliac, IBS + microscopic colitis), exclusion testing still applies

Microbiome composition differences exist on average in IBS cohorts, but no taxon or diversity score diagnoses IBS (Duvallet meta-analysis). Treating a report line as proof of “just IBS” when alarms are present reverses the correct order of evaluation.

Functional overlap pages (after clinical clearance): IBS subtypes, IBD vs functional gut, Chronic bloating.


What to bring to your GP or gastroenterologist

A short prepared summary speeds appropriate testing and reduces duplicate consumer panels.

ItemExamples
Symptom timelineOnset age, constant vs intermittent, relation to meals and stress
Stool patternBristol scale, urgency, nocturnal episodes, blood or mucus
Weight changeIntentional vs unintentional
Medications & supplementsPPIs, opioids, NSAIDs, antibiotics, iron, probiotics
Diet changes already triedLow-FODMAP, gluten-free, fibre increases, duration and effect
Family historyIBD, colorectal cancer, coeliac disease
Prior testsCalprotectin, coeliac serology, colonoscopy, breath tests, dates and results
Microbiome report (if already done)Lab name, method (16S vs shotgun), sample date, not the narrative alone

See also: Talking to clinicians with your report.


Context if you're reading a report

Microbiome reports and wellness framing can delay workup for treatable conditions including inflammatory bowel disease, coeliac disease, colorectal cancer, and infections. Alarm features change the order of testing: clinical assessment first.

Consumer stool panels do not screen for cancer, IBD flares, coeliac serology, acute infection, or anaemia. Calprotectin on some panels is closer to clinical use but still needs interpretation in context.

That a normal microbiome report rules out IBD or cancer; that bloating alone confirms IBS without exclusion of other causes when alarms are present; or that diet trials are safe to run for all symptom patterns without a clinician when red flags apply.

Related on this site: Lacy et al., 2021, Am J Gastroenterol (ACG IBS guideline) , Sperber et al., 2017, Neurogastroenterol Motil (Rome IV overview)